• Je něco špatně v tomto záznamu ?

Medication errors: problems and recommendations from a consensus meeting

members of EMERGE, the Erice Medication Errors Research Group, Abha Agrawal, Jeffrey K. Aronson, Nicky Britten, Robin E. Ferner, Peter A. de Smet, Daniela Fialová, Richard J. Fitzgerald, Robert Likić, Simon R. Maxwell, Ronald H. Meyboom, Pietro...

. 2009 ; 67 (6) : 592-598.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu konsensus - konference, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc14072548

Grantová podpora
NS10029 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK Free Medical Journals od 1974 do 2020
PubMed Central od 1974 do 2020
Europe PubMed Central od 1974 do Před 1 rokem
Wiley Online Library (archiv) od 1974-01-01 do 2012-12-31
Wiley Free Content od 1997 do Před 1 rokem

Here we discuss 15 recommendations for reducing the risks of medication errors: 1. Provision of sufficient undergraduate learning opportunities to make medical students safe prescribers. 2. Provision of opportunities for students to practise skills that help to reduce errors. 3. Education of students about common types of medication errors and how to avoid them. 4. Education of prescribers in taking accurate drug histories. 5. Assessment in medical schools of prescribing knowledge and skills and demonstration that newly qualified doctors are safe prescribers. 6. European harmonization of prescribing and safety recommendations and regulatory measures, with regular feedback about rational drug use. 7. Comprehensive assessment of elderly patients for declining function. 8. Exploration of low-dose regimens for elderly patients and preparation of special formulations as required. 9. Training for all health-care professionals in drug use, adverse effects, and medication errors in elderly people. 10. More involvement of pharmacists in clinical practice. 11. Introduction of integrated prescription forms and national implementation in individual countries. 12. Development of better monitoring systems for detecting medication errors, based on classification and analysis of spontaneous reports of previous reactions, and for investigating the possible role of medication errors when patients die. 13. Use of IT systems, when available, to provide methods of avoiding medication errors; standardization, proper evaluation, and certification of clinical information systems. 14. Nonjudgmental communication with patients about their concerns and elicitation of symptoms that they perceive to be adverse drug reactions. 15. Avoidance of defensive reactions if patients mention symptoms resulting from medication errors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14072548
003      
CZ-PrNML
005      
20230607091023.0
007      
ta
008      
140923s2009 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/j.1365-2125.2009.03414.x $2 doi
035    __
$a (PubMed)19594525
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a enk
100    1_
$a Members of EMERGE, Erice Medication Errors Research Group $u Department of Primary Health Care, Rosemary Rue Building, Old Road Campus, Headington, Oxford OX3 7LF, UK
245    10
$a Medication errors: problems and recommendations from a consensus meeting / $c members of EMERGE, the Erice Medication Errors Research Group, Abha Agrawal, Jeffrey K. Aronson, Nicky Britten, Robin E. Ferner, Peter A. de Smet, Daniela Fialová, Richard J. Fitzgerald, Robert Likić, Simon R. Maxwell, Ronald H. Meyboom, Pietro Minuz, Graziano Onder, Michael Schachter, Giampaolo Velo
504    __
$b 48
520    9_
$a Here we discuss 15 recommendations for reducing the risks of medication errors: 1. Provision of sufficient undergraduate learning opportunities to make medical students safe prescribers. 2. Provision of opportunities for students to practise skills that help to reduce errors. 3. Education of students about common types of medication errors and how to avoid them. 4. Education of prescribers in taking accurate drug histories. 5. Assessment in medical schools of prescribing knowledge and skills and demonstration that newly qualified doctors are safe prescribers. 6. European harmonization of prescribing and safety recommendations and regulatory measures, with regular feedback about rational drug use. 7. Comprehensive assessment of elderly patients for declining function. 8. Exploration of low-dose regimens for elderly patients and preparation of special formulations as required. 9. Training for all health-care professionals in drug use, adverse effects, and medication errors in elderly people. 10. More involvement of pharmacists in clinical practice. 11. Introduction of integrated prescription forms and national implementation in individual countries. 12. Development of better monitoring systems for detecting medication errors, based on classification and analysis of spontaneous reports of previous reactions, and for investigating the possible role of medication errors when patients die. 13. Use of IT systems, when available, to provide methods of avoiding medication errors; standardization, proper evaluation, and certification of clinical information systems. 14. Nonjudgmental communication with patients about their concerns and elicitation of symptoms that they perceive to be adverse drug reactions. 15. Avoidance of defensive reactions if patients mention symptoms resulting from medication errors.
590    __
$a bohemika - dle Pubmed
650    02
$a monitorování léčiv $x normy $7 D016903
650    12
$a monitorování léčiv $7 D016903
650    12
$a lékové předpisy $x normy $7 D011307
650    12
$a studium lékařství $x normy $x organizace a řízení $7 D004501
650    02
$a lidé $7 D006801
650    02
$a interprofesionální vztahy $7 D007400
650    12
$a anamnéza $x normy $7 D008487
650    12
$a medikační omyly $x prevence a kontrola $7 D008508
650    02
$a vztahy mezi zdravotnickým pracovníkem a pacientem $7 D011369
650    12
$a řízení rizik $x normy $x organizace a řízení $7 D012308
655    _2
$a konsensus - konference $7 D016446
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Agrawal, Abha $7 gn_A_00002255
700    1_
$a Aronson, Jeffrey K. $7 gn_A_00008799
700    1_
$a Britten, Nicky
700    1_
$a Ferner, Robin E.
700    1_
$a de Smet, Peter A.
700    1_
$a Fialová, Daniela $7 xx0074268
700    1_
$a Fitzgerald, Richard J.
700    1_
$a Likić, Robert
700    1_
$a Maxwell, Simon R.
700    1_
$a Meyboom, Ronald H.
700    1_
$a Minuz, Pietro
700    1_
$a Onder, Graziano
700    1_
$a Schachter, Michael, $d 1950-2020 $7 xx0302414
700    1_
$a Velo, Giampaolo
773    0_
$t British Journal of Clinical Pharmacology $x 0306-5251 $g Roč. 67, č. 6 (2009), s. 592-598 $w MED00000858
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140923144511 $b ABA008
991    __
$a 20230607091019 $b ABA008
999    __
$a ok $b bmc $g 1040393 $s 871438
BAS    __
$a 3
BMC    __
$a 2009 $b 67 $c 6 $d 592-598 $i 0306-5251 $m British journal of clinical pharmacology $x MED00000858 $n Br J Clin Pharmacol
GRA    __
$a NS10029 $p MZ0
LZP    __
$a 2014-09/abme

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace